Unlocking the Potential of GLP-1 Agonists Beyond Diabetes and Weight Loss
The pharmaceutical industry is eagerly investigating new applications for GLP-1s, but the real opportunity lies in precision medicine.
Childhood Obesity Specialists Struggle to Get GLP-1 Agonists
Here are the challenges faced by pediatric obesity specialists in accessing weight-loss meds approved by the FDA for weight loss in kids 12 years or older.
How Are Weight Loss Medications Covered Globally?
Europe and the U.S. consider whether to provide coverage for GLP-1 agonists.
Best Practices in Childhood Obesity Weight Management
Pediatric obesity experts agree that behavioral interventions, used in conjunction with GLP-1 medications, can be more effective than a standalone tool.
Ethics, Public Opinion, and Lived Experience
Utilizing social media, women have taken it upon themselves to communicate with each other, sharing good news and bad news.
Is the Natural Compound Berberine a Safer Alternative to Weight Loss Medications?
Can berberine, a compound derived from plants, offer a safe alternative to widely-used weight loss medications?
Interesting Things About GLP-1 Receptor Agonists
Regarding the currently existing GLP-1 RA meds, there are a few widely recognized contraindications.
Why Is the Most Recommended Childhood Obesity Treatment Not Readily Available?
For many U.S. parents seeking help for a child with obesity, the most widely endorsed treatment — behavioral counseling — is out of reach. Here’s why.
GLP-1 Agonist Drugs Show Promise for Treating More Conditions
GLP-1 agonist drugs like Ozempic, Wegovy, Mounjaro, and Zepbound are showing promise for treating various conditions beyond their original scope.
Shame, Blame, and Oprah’s Special
Oprah talks candidly about her own experience trying to lose weight in a special that aired on March 18 and is getting a lot of attention.